VIDEO RESOURCES

Video Resources for SARCLISA

A video on how SARCLISA works.

Now Playing:

SARCLISA Trial Design and Results

PFS Results in Lenalidomide-refractory patients

Now Playing:

PFS Results in Lenalidomide-Refractory Patients

PFS Results in Renally Impaired Patients

Now Playing:

PFS Results in Renally Impaired Patients

PFS Results in Patients With High-Risk Cytogenetic Abnormalities

Now Playing:

PFS Results in Patients With High-Risk Cytogenetic Abnormalities

PFS Results in Elderly Patients

Now Playing:

PFS Results in Elderly Patients

MRD Negativity in the IKEMA Trial

Now Playing:

MRD Negativity in the IKEMA Trial

A video on how SARCLISA works.

Now Playing:

SARCLISA Mechanism of Action

A video overview with Dr Mikhael on the latest data for SARCLISA + Kd.

Now Playing:

Join Dr Mikhael as He Discusses the Latest Data for SARCLISA + Kd at a Median Follow-up of 44 Months

1L=first line; Kd=carfilzomib and dexamethasone; MOA=mechanism of action; MRD=minimal (or measurable) residual disease; PFS=progression-free survival.